PADnet studies are typically performed by a medical assistant. Any staff member that knows how to use a blood pressure cuff will be able to use PADnet.
With PADnet, the testing technician just needs to gather the data through systolic blood pressures and PVRs, following your clinical protocols. PADnet automatically calculates ABIs and TBIs, as well as PVR amplitude, and test results can be sent to a nearby vascular specialist for interpretation and care coordination.
Improve patient outcomes
The 5-year mortality of someone with PAD (peripheral artery disease) is 30%1. Patients experiencing some of the early signs of PAD can be treated before the disease progresses, leading to better treatment options.
Optimize Practice Performance
PADnet can have a positive impact on your practice’s bottom line as well. Studies are reimbursable, and the diagnosis of PAD supports the prescription of diabetic shoes and orthotics.
Prevent Diabetic Amputations
Peripheral artery disease and diabetes accounts for 54% of all amputations that occur in the United States2. Through PADnet, you can help prevent your patients from having to suffer an amuptation.
Bend the healthcare cost curve
PADnet is a unique solution, in that it can improve your bottom line while reducing healthcare costs. For example, the annual cost to care for an average Medicare beneficiary is $11,173, but that cost rises to more than $72,000 if the patient has PAD3. With PADnet you lower healthcare costs through the early detection and management of this chronic condition.
1. Hiatt, N.L. et al. (2007). Inter-society consensus for the management of peripheral arterial disease (TASC-II). Journal of Vascular Surgery; 45 (Supp S): S29A.
2. Ziegler‐Graham K, MacKenzie EJ, Ephraim PL, Travison TG, Brookmeyer R. Estimating the Prevalence of Limb Loss in the United States: 2005 to 2050. Archives of Physical Medicine and Rehabilitation2008;89(3):422‐9
3. Source: Jaff MR. Ann Vasc Surg 2010;24:577-87, CMS.gov. CMS releases 2015 national health expenditures and Yost ML. Real cost of PAD 2011. THE SAGE GROUP
* Pending credit approval, while supplies last.